Aberrant expression of ALK and EZH2 in Merkel cell carcinoma.
BMC Cancer
; 17(1): 236, 2017 03 31.
Article
in En
| MEDLINE
| ID: mdl-28359267
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Skin Neoplasms
/
Carcinoma, Merkel Cell
/
Biomarkers, Tumor
/
Receptor Protein-Tyrosine Kinases
/
Enhancer of Zeste Homolog 2 Protein
Type of study:
Prognostic_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
BMC Cancer
Journal subject:
NEOPLASIAS
Year:
2017
Document type:
Article
Affiliation country:
Finland
Country of publication:
United kingdom